Phathom Pharmaceuticals Announces Results from VONO-103, a Phase 1 Study Evaluating Gastric Acid Inhibition of Vonoprazan and Lansoprazole (PREVACID®)
Vonoprazan 20 mg demonstrated significantly greater acid suppressive effects over the 7-day study period compared…
Xero Launches Lite Plan in Indonesia to Help Indonesian Small Businesses Master Their Finances
Xero Launches Lite Plan in the Philippines to Help Filipino Small Businesses Master Their Finances
AP Technologies Acquires Blueacre Technology, Adding Nitinol and Precision Laser Processing to Its Catheter Platform
GMG’s THERMAL-XR(R) to be Applied Exclusively & Distributed to Global Oil and Gas/LNG Industry with Curran International
Kincora Receives Option Payment for Divestment of Mongolian Assets